Ranexa

In the US, Ranexa (ranolazine systemic) is a member of the drug class antianginal agents and is used to treat Angina.

US matches:

• Ranexa

UK matches:

• Ranexa prolonged-release tablets
• Ranexa prolonged-release tablets (SPC)

Ingredient matches for Ranexa

Ranolazine

Ranolazine is reported as an ingredient of Ranexa in the following countries:

• Germany


• Ireland


• Luxembourg


• Spain


• United Kingdom

Ranolazine hydrochloride (a derivative of Ranolazine) is reported as an ingredient of Ranexa in the following countries:

• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.